Abstract
AIMS AND METHOD: Response to antidepressants depends on patients' use. Our objective is to take a look over antidepressants use in a real sample. In determining relevant factors, data were gathered from 550 patients, currently taking antidepressants. The questionnaire included two items, patients' perceived difficulty of following treatment and level of acknowledged non-compliance, which may be considered as a way of approximating the patients' real use of treatment. RESULTS: compliance was poor among the less educated, living in rural areas and receiving concomitant treatment. Use perceived as good in 61.5%, better in affective disorder (69.8%). Patients without response present higher incidence of non-compliance (49.1%). It should be mandatory to explore and reinforce a good use of antidepressants in clinical settings, particularly if the indication is not an affective disorder and in case of multiple treatments, rural setting, and lower educational level. If response is inadequate, compliance must be revised specially.
Keywords: Adherence, antidepressant, antidepressant indication, compliance, patients' perception, treatment response, use of treatment, Venlafaxine, hypochondriac depressive symptoms
Current Drug Therapy
Title: Use and Results of Antidepressant Treatment: Patients' Perception
Volume: 6 Issue: 4
Author(s): Maria-Jose Martin-Vazquez, Mauro Garcia-Toro, Francisco Campoamor, Antonio Pareja, Iratxe Aguirre, Joan Salva and Miquel Roca
Affiliation:
Keywords: Adherence, antidepressant, antidepressant indication, compliance, patients' perception, treatment response, use of treatment, Venlafaxine, hypochondriac depressive symptoms
Abstract: AIMS AND METHOD: Response to antidepressants depends on patients' use. Our objective is to take a look over antidepressants use in a real sample. In determining relevant factors, data were gathered from 550 patients, currently taking antidepressants. The questionnaire included two items, patients' perceived difficulty of following treatment and level of acknowledged non-compliance, which may be considered as a way of approximating the patients' real use of treatment. RESULTS: compliance was poor among the less educated, living in rural areas and receiving concomitant treatment. Use perceived as good in 61.5%, better in affective disorder (69.8%). Patients without response present higher incidence of non-compliance (49.1%). It should be mandatory to explore and reinforce a good use of antidepressants in clinical settings, particularly if the indication is not an affective disorder and in case of multiple treatments, rural setting, and lower educational level. If response is inadequate, compliance must be revised specially.
Export Options
About this article
Cite this article as:
Martin-Vazquez Maria-Jose, Garcia-Toro Mauro, Campoamor Francisco, Pareja Antonio, Aguirre Iratxe, Salva Joan and Roca Miquel, Use and Results of Antidepressant Treatment: Patients' Perception, Current Drug Therapy 2011; 6 (4) . https://dx.doi.org/10.2174/157488511798109619
DOI https://dx.doi.org/10.2174/157488511798109619 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Placental Hypoxia Developed During Preeclampsia Induces Telocytes Apoptosis in Chorionic Villi Affecting The Maternal-Fetus Metabolic Exchange
Current Stem Cell Research & Therapy Use of Clinically Available PPAR Agonists for Heart Failure; Do the Risks Outweigh the Potential Benefits?
Current Molecular Pharmacology Metabolic Syndrome: Sex-Related Cardiovascular Risk and Therapeutic Approach
Current Medicinal Chemistry Mechanisms of Endothelial Dysfunction: Clinical Significance and Preventive Non-Pharmacological Therapeutic Strategies
Current Pharmaceutical Design AMP-Activated Protein Kinase and Type 2 Diabetes
Current Medicinal Chemistry Long Term Stability Evaluation of Prostacyclin Released from Biomedical Device through Turbiscan Lab Expert
Medicinal Chemistry Pharmacotherapy & Surgical Interventions Available for Obesity Management and Importance of Pancreatic Lipase Inhibitory Phytomolecules as Safer Anti-Obesity Therapeutics
Mini-Reviews in Medicinal Chemistry Current Strategies and Drug Targets in the Management of Type 2 Diabetes Mellitus
Current Drug Targets A Review on the Effects of New Anti-Diabetic Drugs on Platelet Function
Endocrine, Metabolic & Immune Disorders - Drug Targets Testicular Dysfunction is a Common Feature in Men with Type 2 Diabetes Mellitus in a Nigerian Tertiary Hospital
Current Diabetes Reviews Immunosuppressive and Antiviral Treatment of Inflammatory Cardiomyopathy
Recent Patents on Cardiovascular Drug Discovery Endothelial Function: A Surrogate Endpoint in Cardiovascular Studies?
Current Pharmaceutical Design Peripheral Arterial Disease: The Magnitude of the Problem and its Socioeconomic Impact
Current Drug Targets - Cardiovascular & Hematological Disorders Autoimmune Polyendocrine Syndrome Complicated by Pulmonary Hypertension
Endocrine, Metabolic & Immune Disorders - Drug Targets Folate Nutrigenetics: A Convergence of Dietary Folate Metabolism, Folic Acid Supplementation, and Folate Antagonist Pharmacogenetics
Drug Metabolism Letters Glycoxidation of Low Density Lipoprotein in Impaired Glucose Tolerance: Implications for the Pathogenesis of Diabetic Vascular Disease
Vascular Disease Prevention (Discontinued) Statins in the Treatment of Acute Ischemic Stroke
Current Pharmaceutical Biotechnology Immune Regulation by the Posttranslational Modification O-GlcNAc
Current Signal Transduction Therapy Diabetes Mellitus and Osteoporosis Correlation: Challenges and Hopes
Current Diabetes Reviews The Immunoregulatory Activity of Mesenchymal Stem Cells: ‘State of Art’ and ‘Future Avenues’
Current Medicinal Chemistry